HK1026264A1 - Reagents for the detection and quantification of thryoxine in fluid samples - Google Patents
Reagents for the detection and quantification of thryoxine in fluid samplesInfo
- Publication number
- HK1026264A1 HK1026264A1 HK00103115A HK00103115A HK1026264A1 HK 1026264 A1 HK1026264 A1 HK 1026264A1 HK 00103115 A HK00103115 A HK 00103115A HK 00103115 A HK00103115 A HK 00103115A HK 1026264 A1 HK1026264 A1 HK 1026264A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- thryoxine
- quantification
- reagents
- detection
- fluid samples
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 239000012530 fluid Substances 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/859,775 US5352803A (en) | 1992-03-30 | 1992-03-30 | 5(6)-methyl substituted fluorescein derivatives |
| US07/973,140 US5359093A (en) | 1992-03-30 | 1992-11-06 | Reagents and methods for the detection and quantification of thyroxine in fluid samples |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1026264A1 true HK1026264A1 (en) | 2000-12-08 |
Family
ID=27127537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00103115A HK1026264A1 (en) | 1992-03-30 | 2000-05-24 | Reagents for the detection and quantification of thryoxine in fluid samples |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5593896A (de) |
| EP (1) | EP0649533B1 (de) |
| JP (1) | JP3327551B2 (de) |
| CA (1) | CA2131727A1 (de) |
| DE (2) | DE69332988T2 (de) |
| ES (2) | ES2148225T3 (de) |
| HK (1) | HK1026264A1 (de) |
| WO (1) | WO1993020442A1 (de) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2390425T3 (es) | 2000-12-22 | 2012-11-12 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Uso de moléculas de orientación repulsivas (RGM) y sus moduladores |
| JP2009510002A (ja) * | 2005-09-30 | 2009-03-12 | アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 反発誘導分子（ｒｇｍ）タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用 |
| US7993855B2 (en) * | 2006-03-24 | 2011-08-09 | Aokin Ag | Use of additives to lower the rate of a binding reaction |
| US20080102535A1 (en) * | 2006-11-01 | 2008-05-01 | Chace Donald H | Measuring thyroxine levels from dried blood samples using mass spectrometry |
| EP2033971A1 (de) * | 2007-09-06 | 2009-03-11 | Abbott GmbH & Co. KG | Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| EP2282769A4 (de) | 2008-04-29 | 2012-04-25 | Abbott Lab | Dual-variable- domain-immunglobuline und ihre verwendungen |
| US20090286256A1 (en) * | 2008-05-19 | 2009-11-19 | Abbott Laboratories | Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides |
| US20090286329A1 (en) * | 2008-05-19 | 2009-11-19 | Abbott Laboratoires | Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides |
| CA2726087A1 (en) | 2008-06-03 | 2009-12-10 | Tariq Ghayur | Dual variable domain immunoglobulins and uses thereof |
| US9109026B2 (en) | 2008-06-03 | 2015-08-18 | Abbvie, Inc. | Dual variable domain immunoglobulins and uses thereof |
| US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| CN105254758A (zh) | 2009-03-05 | 2016-01-20 | Abbvie公司 | Il-17结合蛋白 |
| US8501420B2 (en) * | 2009-08-31 | 2013-08-06 | Abbott Laboratories | Biomarkers for prediction of major adverse cardiac events and uses thereof |
| CA2780069C (en) * | 2009-12-08 | 2018-07-17 | Abbott Gmbh & Co. Kg | Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration |
| US20110229921A1 (en) | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
| WO2011129382A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Japan Co. Ltd. | Methods and reagents for diagnosing rheumatoid arthritis |
| TWI615405B (zh) | 2010-05-14 | 2018-02-21 | 艾伯維有限公司 | Ｉｌ-１結合蛋白 |
| US9551714B2 (en) | 2010-06-25 | 2017-01-24 | Abbott Laboratories | Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies |
| WO2012006500A2 (en) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
| UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| CN103298834A (zh) | 2010-08-03 | 2013-09-11 | Abbvie公司 | 双重可变结构域免疫球蛋白及其用途 |
| JP5713602B2 (ja) * | 2010-08-20 | 2015-05-07 | 富士フイルム株式会社 | チロキシンとアルブミンとの結合体を製造する方法 |
| US20120115244A1 (en) | 2010-11-09 | 2012-05-10 | Abbott Laboratories | Materials and methods for immunoassay of pterins |
| MX2013007332A (es) | 2010-12-21 | 2014-01-23 | Abbvie Inc | Inmunoglobulinas de dominio variable doble biespecificas de il-1 alfa y beta y su uso. |
| RU2014120981A (ru) | 2011-10-24 | 2015-12-10 | Эббви Инк. | Иммунные связывающие агенты против склеростина |
| RU2014121043A (ru) | 2011-10-24 | 2015-12-10 | Эббви Инк. | Биспецифические иммуносвязывающие средства, направленные против tnf и il-17 |
| EP2791173B1 (de) | 2011-12-14 | 2020-07-29 | AbbVie Deutschland GmbH & Co. KG | Zusammensetzung und verfahren zur diagnose und behandlung von durch eisenmangel bedingten erkrankungen |
| CA2855570A1 (en) | 2011-12-14 | 2013-06-20 | AbbVie Deutschland GmbH & Co. KG | Composition and method for the diagnosis and treatment of iron-related disorders |
| US8993248B2 (en) | 2011-12-31 | 2015-03-31 | Abbott Laboratories | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use |
| MY194587A (en) | 2012-01-27 | 2022-12-05 | Abbvie Inc | Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration |
| BR112014018717A8 (pt) | 2012-03-13 | 2017-07-11 | Abbvie Inc | Método para selecionar ou identificar um sujeito para terapia de antagonista de v1b |
| TW201402608A (zh) | 2012-07-12 | 2014-01-16 | Abbvie Inc | Ｉｌ－１結合蛋白質 |
| GB2546213B (en) | 2013-02-02 | 2017-12-06 | Univ Duke | Method of isolating circulating tumour cells |
| CN105228649B (zh) | 2013-03-14 | 2019-01-18 | 雅培制药有限公司 | Hcv抗原-抗体组合测定和方法以及用在其中的组合物 |
| EP2970947A4 (de) | 2013-03-14 | 2016-10-12 | Abbott Lab | Rekombinante hcv-ns3-antigene und mutanten für den verbesserten nachweis von antikörpern |
| EP3564384A1 (de) | 2013-03-14 | 2019-11-06 | Abbott Laboratories | Monoklonale antikörper gegen hcv-core lipid-bindender domäne |
| US9005901B2 (en) | 2013-03-15 | 2015-04-14 | Abbott Laboratories | Assay with internal calibration |
| US9469686B2 (en) | 2013-03-15 | 2016-10-18 | Abbott Laboratories | Anti-GP73 monoclonal antibodies and methods of obtaining the same |
| US9157910B2 (en) | 2013-03-15 | 2015-10-13 | Abbott Laboratories | Assay with increased dynamic range |
| WO2015031626A1 (en) | 2013-08-28 | 2015-03-05 | Abbvie Inc. | Soluble cmet assay |
| JP2017521654A (ja) | 2014-06-27 | 2017-08-03 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | ヒトペギウイルス２（ＨＰｇＶ−２）を検出するための組成物および方法 |
| CN104262250A (zh) * | 2014-09-01 | 2015-01-07 | 深圳市美凯特科技有限公司 | 三碘代甲状腺素半抗原发光标记物及合成方法 |
| WO2016069762A2 (en) | 2014-10-29 | 2016-05-06 | Abbott Laboratories | Subject anti-hcv antibody detection assays employing ns3 capture peptides |
| JP2018518655A (ja) | 2015-04-03 | 2018-07-12 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | サンプル分析用デバイス及び方法 |
| CA2981515A1 (en) | 2015-04-03 | 2016-10-06 | Abbott Laboratories | Devices and methods for sample analysis |
| US20170089905A1 (en) | 2015-09-28 | 2017-03-30 | Abbott Japan Co., Ltd. | Methods of diagnosing hepatocellular carcinoma and pancreatic cancer |
| AU2017339858B2 (en) | 2016-10-03 | 2022-02-17 | Abbott Laboratories | Improved methods of assessing GFAP status in patient samples |
| CN109863396B (zh) | 2016-10-05 | 2021-11-05 | 雅培实验室 | 用于样品分析的装置和方法 |
| JP7346300B2 (ja) | 2017-03-23 | 2023-09-19 | アボット・ラボラトリーズ | 早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法 |
| US10877048B2 (en) | 2017-04-15 | 2020-12-29 | Abbott Laboratories | Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers |
| WO2018200823A1 (en) | 2017-04-28 | 2018-11-01 | Abbott Laboratories | Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject |
| CA3078725A1 (en) | 2017-05-25 | 2018-11-29 | Abbott Laboratories | Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers |
| EP3631467A1 (de) | 2017-05-30 | 2020-04-08 | Abbott Laboratories | Verfahren zur hilfe bei der diagnose und evaluierung einer leichten traumatischen hirnläsion bei einer person unter verwendung von herztroponin i |
| CA3068041C (en) | 2017-07-03 | 2024-06-25 | Abbott Laboratories | Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood |
| EP3661537A4 (de) | 2017-08-03 | 2021-06-09 | The Cleveland Clinic Foundation | Verbesserte peptidexpression und apo-h-spezifische antikörper-detektion |
| EP3721234A1 (de) | 2017-12-09 | 2020-10-14 | Abbott Laboratories | Verfahren zur unterstützung bei der diagnose und bewertung einer traumatischen hirnverletzung beim menschen mit einer kombination aus gfap und uch-l1 |
| CA3067057A1 (en) | 2017-12-09 | 2019-06-13 | Abbott Laboratories | Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1) |
| CN111699391A (zh) | 2017-12-29 | 2020-09-22 | 雅培实验室 | 用于诊断和评估创伤性脑损伤的新型生物标志物和方法 |
| US11249091B2 (en) | 2018-02-22 | 2022-02-15 | The Cleveland Clinic Foundation | Detection of glucuronidated and 3-bromotyrosine |
| WO2019213583A1 (en) | 2018-05-04 | 2019-11-07 | Abbott Laboratories | Sequential sampling method for improving immunoassay sensitivity and kinetics of small volume samples |
| WO2020180695A1 (en) | 2019-03-01 | 2020-09-10 | Abbott Laboratories | Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease |
| EP4136459A1 (de) | 2020-04-13 | 2023-02-22 | Abbott Laboratories | Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe |
| US20220043000A1 (en) | 2020-08-04 | 2022-02-10 | Abbott Laboratories | Methods and kits for detecting sars-cov-2 protein in a sample |
| WO2022119841A1 (en) | 2020-12-01 | 2022-06-09 | Abbott Laboratories | Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi |
| WO2023102384A1 (en) | 2021-11-30 | 2023-06-08 | Abbott Laboratories | Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi |
| WO2022147147A1 (en) | 2020-12-30 | 2022-07-07 | Abbott Laboratories | Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample |
| AU2022264434A1 (en) | 2021-04-29 | 2023-11-02 | Abbott Laboratories | Systems and methods for pooling samples for high-throughput analysis |
| CA3216320A1 (en) | 2021-05-18 | 2022-11-24 | Abbott Laboratories | Methods of evaluating brain injury in a pediatric subject |
| US20240118279A1 (en) | 2021-06-14 | 2024-04-11 | Abbott Laboratories | Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind |
| EP4392783A1 (de) | 2021-08-27 | 2024-07-03 | Abbott Laboratories | Verfahren zum nachweis von immunoglobulin g, subklassen 4 (igg4) in einer biologischen probe |
| AU2022339759A1 (en) | 2021-08-31 | 2024-03-07 | Abbott Laboratories | Methods and systems of diagnosing brain injury |
| AU2022354059A1 (en) | 2021-09-30 | 2024-03-28 | Abbott Laboratories | Methods and systems of diagnosing brain injury |
| AU2022413677A1 (en) | 2021-12-17 | 2024-06-27 | Abbott Laboratories | Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples |
| AU2022423989A1 (en) | 2021-12-28 | 2024-07-04 | Abbott Laboratories | Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan |
| WO2024006876A1 (en) | 2022-06-29 | 2024-01-04 | Abbott Laboratories | Magnetic point-of-care systems and assays for determining gfap in biological samples |
| WO2024059708A1 (en) | 2022-09-15 | 2024-03-21 | Abbott Laboratories | Biomarkers and methods for differentiating between mild and supermild traumatic brain injury |
| WO2024107430A1 (en) | 2022-11-17 | 2024-05-23 | Regeneron Pharmaceuticals, Inc. | Methods for assaying enzyme activity |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3714344A (en) * | 1969-05-01 | 1973-01-30 | Mallinckrodt Chemical Works | Method for determining thyroxine in blood serum and reagent therefor |
| US4040907A (en) * | 1974-06-20 | 1977-08-09 | Syva Company | Iodothyronine enzyme conjugates |
| NL7605447A (nl) * | 1975-06-26 | 1976-12-28 | Byk Mallinckrodt Chem Prod | Radioimmunoproefmethode voor de bepaling van thyroxine. |
| US4307071A (en) * | 1977-08-02 | 1981-12-22 | Kallestad Laboratories, Inc. | Analytical reagent and method |
| US4329461A (en) * | 1980-01-11 | 1982-05-11 | Syva Company | Fluorescent thyroid hormone conjugates and their uses |
| US4391795A (en) * | 1980-03-21 | 1983-07-05 | Becton Dickinson And Company | Assay for free thyroid hormone |
| DE73865T1 (de) * | 1981-09-11 | 1983-07-21 | Amersham International Plc, Amersham, Buckinghamshire | Iodthyronin-derivate und ihre anwendung zur bestimmung freier iodthyronin-verbindungen. |
| US4668640A (en) * | 1981-12-11 | 1987-05-26 | Abbott Laboratories | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins |
| US4476228A (en) * | 1982-11-08 | 1984-10-09 | Abbott Laboratories | Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques |
| US4476229A (en) * | 1982-11-08 | 1984-10-09 | Abbott Laboratories | Substituted carboxyfluoresceins |
| US4614823A (en) * | 1982-11-08 | 1986-09-30 | Abbott Laboratories | Aminomethylfluorescein derivatives |
| US4510251A (en) * | 1982-11-08 | 1985-04-09 | Abbott Laboratories | Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers |
| US4636478A (en) * | 1984-07-16 | 1987-01-13 | Becton, Dickinson And Company | Monoclonal antibodies recognizing L-thyroxine |
| DE3504406A1 (de) * | 1985-02-08 | 1986-08-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung der bindungskapazitaet des thyroxin bindenden globulins |
| DE3751673T2 (de) * | 1986-10-24 | 1996-08-01 | Abbott Lab | Test, Indikatoren, Immunogene und Antikörper für Benzodiazepine |
| US4912208A (en) * | 1987-06-29 | 1990-03-27 | Abbott Laboratories | Fluorophores for encapsulation into liposomes |
| US5145790A (en) * | 1990-05-04 | 1992-09-08 | Abbott Laboratories | Reagents and method for detecting polychlorinated biphenyls |
| ES2084069T3 (es) * | 1990-08-15 | 1996-05-01 | Abbott Lab | Reactivos de inmunoensayo y metodo para la determinacion de ciclosporina. |
| DE69229174T2 (de) * | 1991-08-23 | 1999-09-16 | Molecular Probes, Inc. | Verwendung von haloalkylderivaten von reportermolekülen zur analyse der metabolischen aktivität in zellen |
| US5296599A (en) * | 1991-09-19 | 1994-03-22 | Millipore Corporation | Activated carbamates compounds |
-
1993
- 1993-03-29 ES ES93908638T patent/ES2148225T3/es not_active Expired - Lifetime
- 1993-03-29 CA CA002131727A patent/CA2131727A1/en not_active Abandoned
- 1993-03-29 EP EP93908638A patent/EP0649533B1/de not_active Expired - Lifetime
- 1993-03-29 ES ES99115138T patent/ES2198823T3/es not_active Expired - Lifetime
- 1993-03-29 DE DE69332988T patent/DE69332988T2/de not_active Expired - Lifetime
- 1993-03-29 WO PCT/US1993/002909 patent/WO1993020442A1/en active IP Right Grant
- 1993-03-29 JP JP51759693A patent/JP3327551B2/ja not_active Expired - Lifetime
- 1993-03-29 DE DE69328622T patent/DE69328622T2/de not_active Expired - Lifetime
-
1994
- 1994-07-13 US US08/275,064 patent/US5593896A/en not_active Expired - Lifetime
-
1995
- 1995-05-18 US US08/443,833 patent/US5648272A/en not_active Expired - Lifetime
-
2000
- 2000-05-24 HK HK00103115A patent/HK1026264A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07505714A (ja) | 1995-06-22 |
| CA2131727A1 (en) | 1993-10-14 |
| ES2198823T3 (es) | 2004-02-01 |
| EP0649533A1 (de) | 1995-04-26 |
| DE69332988D1 (de) | 2003-06-18 |
| EP0649533B1 (de) | 2000-05-10 |
| DE69328622T2 (de) | 2001-02-08 |
| JP3327551B2 (ja) | 2002-09-24 |
| EP0649533A4 (de) | 1996-08-21 |
| US5648272A (en) | 1997-07-15 |
| WO1993020442A1 (en) | 1993-10-14 |
| DE69328622D1 (de) | 2000-06-15 |
| ES2148225T3 (es) | 2000-10-16 |
| US5593896A (en) | 1997-01-14 |
| DE69332988T2 (de) | 2004-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1026264A1 (en) | Reagents for the detection and quantification of thryoxine in fluid samples | |
| AU2418192A (en) | Method and device for detecting the presence of analyte in a sample | |
| GB2114737B (en) | An integral multilayer analytical elememt for ammonia determination and use thereof in detection of ammonia or an ammonia-forming substrate | |
| HUP9702463A3 (en) | Process and compounds for the magnetorelaxometric detection of analytes and use thereof | |
| AU6609994A (en) | Analyte detection device and process | |
| AU5964494A (en) | Assays and kits for detecting analytes in the presence of cross-reacting substances | |
| IL105813A0 (en) | Method and system for sampling and determining the presence of compounds in containers | |
| GB9218946D0 (en) | Process for the detection and quantification of corrosion and scale inhibitors in produced well fluids | |
| EP0521421A3 (en) | Method for analysis of liquid samples and substrate for analysis of liquid sample employed in the method | |
| AU4716093A (en) | Analytical method for the detection and measurement of paracetamol | |
| AU1186695A (en) | Reagents and methods for the detection of methotrexate | |
| IL106273A0 (en) | Rapid detection of biopolymers in stained specimens | |
| GB9215741D0 (en) | Method and apparatus for the measurement of pollutants in liquids | |
| IL117182A0 (en) | Method and reagent for the specific determination of ldl in serum samples | |
| AU3190389A (en) | Composition for simple detection and/or quantification of antigenic substances in body liquids | |
| AU6886094A (en) | Analyte detection device and process | |
| ZA944024B (en) | Immunoassay reagents and methods for detecting brequinar and analoges | |
| EP0572968A3 (de) | Verfahren und Vorrichtung zur Vorbereitung flüssiger Proben auf die Analyse. | |
| EP0410893A3 (en) | Determination and detection of antibody and its immunoglobulin class | |
| EP0550883A3 (en) | Method and reagents for determining the presence of giardia lamblia | |
| EP0409345A3 (en) | Analytical element and method for the determination of creatinine | |
| EP0601275A3 (de) | Verfahren und Vorrichtung zum automatischen Zugeben von flüssigen Reagenzien in einen Probenbehälter. | |
| EP0579343A3 (de) | Verfahren und Vorrichtung zum Nachweis von Analyten in Flüssigkeiten. | |
| IL86520A0 (en) | Method for the detection of anions and analytical reagents therefor | |
| GB9220943D0 (en) | Assay reagent and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080329 |